Camden Capital, LLC Abbott Laboratories Transaction History

Camden Capital, LLC

$896 Million
Q3 2024

A detailed history of Camden Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Camden Capital, LLC holds 4,663 shares of ABT stock, worth $546,783. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,663

Previous 4,568 2.08%

Holding current value

$546,783

Previous $474,000 12.03%

% of portfolio

0.06%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $9,506 - $11,222	95 Added 2.08%	4,663 $531,000
Q2 2024 Aug 06, 2024	SELL	$100.73 - $112.44 $118,055 - $131,779	-1,172 Reduced 20.42%	4,568 $474,000
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $80,168 - $88,542	732 Added 14.62%	5,740 $652,000
Q4 2023 Feb 05, 2024	BUY	$90.19 - $110.4 $14,159 - $17,332	157 Added 3.24%	5,008 $551,000
Q3 2023 Nov 03, 2023	BUY	$95.53 - $114.62 $30,951 - $37,136	324 Added 7.16%	4,851 $469,000
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $104,811 - $116,781	1,040 Added 29.83%	4,527 $493,000
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $2,421 - $2,850	-25 Reduced 0.71%	3,487 $353,000
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $8,175 - $9,590	86 Added 2.51%	3,512 $385,000
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $79,052 - $91,528	817 Added 31.31%	3,426 $331,000
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $91,965 - $111,156	-901 Reduced 25.67%	2,609 $284,000
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $166,241 - $202,720	1,458 Added 71.05%	3,510 $415,000
Q4 2021 Feb 28, 2022	SELL	$115.53 - $141.46 $264,910 - $324,367	-2,293 Reduced 52.77%	2,052 $289,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $62,155 - $76,105	538 Added 14.13%	4,345 $612,000
Q3 2021 Nov 03, 2021	SELL	$116.66 - $129.06 $8,399 - $9,292	-72 Reduced 1.86%	3,807 $450,000
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $63,368 - $74,593	599 Added 18.26%	3,879 $450,000
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $82,718 - $97,454	760 Added 30.16%	3,280 $393,000
Q4 2020 Feb 04, 2021	BUY	$105.0 - $114.42 $19,740 - $21,510	188 Added 8.06%	2,520 $276,000
Q3 2020 Oct 30, 2020	BUY	$91.64 - $111.29 $213,704 - $259,528	2,332 New	2,332 $254,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Account

Camden Capital, LLC Abbott Laboratories Transaction History